Biodesix, Inc. (BDSX), a diagnostic solutions company continues to make strides in advancing its innovative lung cancer diagnostics.
The performance of the company's Nodify CDT blood-based test has been reaffirmed in a post-market clinical validation study published in the CHEST Pulmonary Journal.
The test, which measures seven autoantibodies associated with lung cancer, helps identify high-risk nodules that may require further evaluation or intervention was launched in March 2020.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.